BRCA2 and ovarian cancer: Despite the inherent differences in clinical manifestation between breast and ovarian cancer, a portion of these malignancies are intrinsically linked, as women with specific inherited germline mutations including BRCA1, BRCA2, PALB2, TP53, CDH1, and PTEN have an increased lifetime risk of developing either disease [64,65].